Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to l-dopa in a Parkinson’s animal model
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to l-dopa in a Parkinson’s animal model
Authors
Keywords
-
Journal
AMINO ACIDS
Volume 43, Issue 3, Pages 1359-1367
Publisher
Springer Nature
Online
2012-01-05
DOI
10.1007/s00726-011-1210-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity
- (2010) Alba Minelli et al. FREE RADICAL BIOLOGY AND MEDICINE
- Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats
- (2010) Kyung Hee Jung et al. JOURNAL OF PINEAL RESEARCH
- Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1
- (2010) Nadia G. Innamorato et al. PLoS One
- Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
- (2009) Ana I. Rojo et al. GLIA
- The N-terminal tripeptide of insulin-like growth factor-I protects against β-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3β modulation
- (2009) Emma Burgos-Ramos et al. JOURNAL OF NEUROCHEMISTRY
- Cyclo(His-Pro) up-regulates heme oxygenase 1 via activation of Nrf2-ARE signalling
- (2009) Alba Minelli et al. JOURNAL OF NEUROCHEMISTRY
- Etiology and Pathogenesis of Parkinson Disease
- (2009) Anthony H.V. Schapira NEUROLOGIC CLINICS
- Delayed peripheral administration of the N-terminal tripeptide of IGF-1 (GPE) reduces brain damage following microsphere induced embolic damage in young adult and aged rats
- (2009) Shlomo Shapira et al. NEUROSCIENCE LETTERS
- L-dopa therapy for Parkinson's disease: Past, present, and future
- (2009) Toshiharu Nagatsu et al. PARKINSONISM & RELATED DISORDERS
- Toxic effects of dopamine metabolism in Parkinson's disease
- (2009) Nobutaka Hattori et al. PARKINSONISM & RELATED DISORDERS
- L-DOPA Neurotoxicity Is Mediated by Up-Regulation of DMT1−IRE Expression
- (2009) Fang Du et al. PLoS One
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
- (2009) Pei-Chun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interaction Among Heme Oxygenase, Nuclear Factor-κB, and Transcription Activating Factors in Cardiac Hypertrophy in Hypertension
- (2008) Ashok Jadhav et al. HYPERTENSION
- Codrugs Linkingl-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease
- (2008) Francesco Pinnen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging
- (2007) Antero Salminen et al. AGEING RESEARCH REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now